deCODE biostructures, Inc., has announced that it has received a five-year, $13.5 million collaborative subcontract from the Seattle Biomedical Research Institute which has been funded by the National ...
deCODE chemistry and biostructures Details Role of Structure-based Drug Design in the Development of DG-041, deCODE's novel antiplatelet for prevention of acute thrombosis without the side effect of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback